• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

入院时高血糖可预测无糖尿病的患者行直接经皮冠状动脉介入治疗后的住院期间死亡率和主要不良心脏事件。

Admission hyperglycemia predicts inhospital mortality and major adverse cardiac events after primary percutaneous coronary intervention in patients without diabetes mellitus.

机构信息

1Clinic of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center Training and Research Hospital, Istanbul, Turkey.

出版信息

Angiology. 2014 Feb;65(2):154-9. doi: 10.1177/0003319713488930. Epub 2013 May 8.

DOI:10.1177/0003319713488930
PMID:23657174
Abstract

Admission hyperglycemia is associated with high inhospital and long-term adverse events in patients that undergo primary percutaneous coronary intervention (PCI). We aimed to evaluate whether hyperglycemia predicts inhospital mortality. We prospectively analyzed 503 consecutive patients. The patients were divided into tertiles according to the admission glucose levels. Tertile I: glucose <118 mg/dL (n = 166), tertile II: glucose 118 to 145 mg/dL (n = 168), and tertile III: glucose >145 mg/dL (n = 169). Inhospital mortality was 0 in tertile I, 2 in tertile II, and 9 in tertile III (P < .02). Cardiogenic shock occurred more frequently in tertile III compared to tertiles I and II (10% vs 4.1% and 0.6%, respectively, P = .01). Multivariate logistic regression analysis revealed that patients in tertile III had significantly higher risk of inhospital major adverse cardiac events compared to patients in tertile I (odds ratio: 9.55, P < .02). Admission hyperglycemia predicts inhospital adverse cardiac events in mortality and acute ST-segment elevation myocardial infarction in patients that underwent primary PCI.

摘要

入院时的高血糖与行直接经皮冠状动脉介入治疗(PCI)的患者住院期间和长期的不良事件有关。我们旨在评估高血糖是否可以预测住院期间的死亡率。我们前瞻性地分析了 503 例连续患者。根据入院时的血糖水平,患者被分为三分位。三分位 I:血糖 <118mg/dL(n = 166);三分位 II:血糖 118 至 145mg/dL(n = 168);三分位 III:血糖 >145mg/dL(n = 169)。三分位 I 患者住院期间死亡率为 0,三分位 II 患者为 2,三分位 III 患者为 9(P <.02)。与三分位 I 和 II 相比,三分位 III 患者发生心源性休克的频率更高(分别为 10%、4.1%和 0.6%,P =.01)。多变量逻辑回归分析显示,与三分位 I 患者相比,三分位 III 患者住院期间发生主要不良心脏事件的风险显著更高(比值比:9.55,P <.02)。在直接 PCI 治疗的患者中,入院时的高血糖可预测住院期间死亡率和急性 ST 段抬高型心肌梗死的不良心脏事件。

相似文献

1
Admission hyperglycemia predicts inhospital mortality and major adverse cardiac events after primary percutaneous coronary intervention in patients without diabetes mellitus.入院时高血糖可预测无糖尿病的患者行直接经皮冠状动脉介入治疗后的住院期间死亡率和主要不良心脏事件。
Angiology. 2014 Feb;65(2):154-9. doi: 10.1177/0003319713488930. Epub 2013 May 8.
2
Impact of stress hyperglycemia on in-hospital stent thrombosis and prognosis in nondiabetic patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.应激性高血糖对接受直接经皮冠状动脉介入治疗的非糖尿病ST段抬高型心肌梗死患者院内支架内血栓形成及预后的影响
Coron Artery Dis. 2013 Aug;24(5):352-6. doi: 10.1097/MCA.0b013e328361a942.
3
Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.入院时的血糖水平可预测行经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死合并心原性休克患者的院内和长期死亡率。
Kardiol Pol. 2010 Jul;68(7):743-51.
4
The relationship between γ-glutamyl transferase levels and the clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者γ-谷氨酰转移酶水平与临床结局的关系
Coron Artery Dis. 2013 Jun;24(4):272-8. doi: 10.1097/MCA.0b013e328360d131.
5
What level of hyperglycaemia on admission indicates a poor prognosis in patients with myocardial infarction treated invasively?入院时的高血糖水平表明接受介入治疗的心肌梗死患者预后不良的程度如何?
Kardiol Pol. 2012;70(6):564-72.
6
Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction.急性高血糖症与 ST 段抬高型心肌梗死患者的炎症反应。
Kardiol Pol. 2013;71(3):260-7. doi: 10.5603/KP.2013.0038.
7
Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era.在冠状动脉介入治疗时代,急性高血糖与急性心肌梗死后的不良结局相关。
Am Heart J. 2005 Oct;150(4):814-20. doi: 10.1016/j.ahj.2004.12.020.
8
Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.血浆B型利钠肽水平可预测急性ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时的心肌组织灌注情况。
Coron Artery Dis. 2011;22(6):405-10. doi: 10.1097/MCA.0b013e3283487dac.
9
Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.中性粒细胞/淋巴细胞比值与 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后住院期间主要不良心脏事件的关系。
Am J Cardiol. 2012 Sep 1;110(5):621-7. doi: 10.1016/j.amjcard.2012.04.041. Epub 2012 May 18.
10
Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.尿酸对行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者的预后价值。
Am J Cardiol. 2012 Feb 15;109(4):486-91. doi: 10.1016/j.amjcard.2011.09.042. Epub 2011 Nov 17.

引用本文的文献

1
Acute Hyperglycemia-Induced Injury in Myocardial Infarction.急性高血糖诱导的心肌梗死损伤。
Int J Mol Sci. 2024 Aug 4;25(15):8504. doi: 10.3390/ijms25158504.
2
Long-Term Prognostic Impact of Stress Hyperglycemia in Non-Diabetic Patients Treated with Successful Primary Percutaneous Coronary Intervention.成功接受直接经皮冠状动脉介入治疗的非糖尿病患者应激性高血糖的长期预后影响
J Pers Med. 2024 May 31;14(6):591. doi: 10.3390/jpm14060591.
3
Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis.
ST段抬高型心肌梗死患者的应激性高血糖与不良预后:一项系统评价和荟萃分析。
Front Cardiovasc Med. 2024 Mar 11;11:1303685. doi: 10.3389/fcvm.2024.1303685. eCollection 2024.
4
Cardiovascular protective effect of sodium-glucose cotransporter 2 inhibitors on patients with acute coronary syndrome and type 2 diabetes mellitus: a retrospective study.钠-葡萄糖共转运蛋白 2 抑制剂对急性冠状动脉综合征合并 2 型糖尿病患者的心血管保护作用:一项回顾性研究。
BMC Cardiovasc Disord. 2023 Oct 7;23(1):495. doi: 10.1186/s12872-023-03542-y.
5
Association of admission hyperglycemia and all-cause mortality in acute myocardial infarction with percutaneous coronary intervention: A dose-response meta-analysis.急性心肌梗死接受经皮冠状动脉介入治疗时入院高血糖与全因死亡率的关联:一项剂量反应荟萃分析。
Front Cardiovasc Med. 2022 Sep 12;9:932716. doi: 10.3389/fcvm.2022.932716. eCollection 2022.
6
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? .接受经皮冠状动脉介入治疗的患者的血糖控制:新型抗糖尿病药物的作用是什么?
Int J Mol Sci. 2022 Jun 30;23(13):7261. doi: 10.3390/ijms23137261.
7
Admission hyperglycemia in acute myocardial infarction is associated with an increased risk of arrhythmias: A systematic review and meta-analysis.急性心肌梗死入院时高血糖与心律失常风险增加相关:一项系统评价和荟萃分析。
J Arrhythm. 2022 Apr 12;38(3):307-315. doi: 10.1002/joa3.12708. eCollection 2022 Jun.
8
Impact of stress hyperglycemia on myocardial salvage in patients with ST-Elevation myocardial infarction: Cardiac magnetic resonance study.应激性高血糖对 ST 段抬高型心肌梗死患者心肌挽救的影响:心脏磁共振研究。
Indian Heart J. 2020 Sep-Oct;72(5):462-465. doi: 10.1016/j.ihj.2020.08.011. Epub 2020 Aug 19.
9
At-admission hyperglycemia is consistently associated with poor prognosis and early intervention can improve outcomes in patients with COVID-19.入院时的高血糖与预后不良密切相关,早期干预可以改善 COVID-19 患者的结局。
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1641-1644. doi: 10.1016/j.dsx.2020.08.034. Epub 2020 Aug 29.
10
Association of Hyperglycemia and Final TIMI Flow with One-Year Mortality of Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI.急性ST段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗时高血糖及最终心肌梗死溶栓试验血流分级与1年死亡率的关系
Int J Angiol. 2019 Sep;28(3):182-187. doi: 10.1055/s-0039-1691811. Epub 2019 Jun 17.